Helixir is in early access. Research and biotech teams can apply to run the Co-Scientist programs on their own target or open question, with the programs an account opens confirmed during evaluation.
Early access is granted case by case, for research use, and clinical trial designs require expert review. Teams that need a programme scoped around an existing pipeline can ask about a custom engagement in the same application.
